Hereditary Endocrine Cancer Group

Home | Research & Innovation | Scientific Programmes | Human Cancer Genetics Programme | Hereditary Endocrine Cancer Group

Mercedes Robledo
Mercedes Robledo Group Leader
T +34 917328000 (Ext 3320)

Staff Scientists

  • Alberto Cascón
  • Cristina Rodríguez

Post-Doctoral Fellows

  • Luis Javier Leandro
  • Ángel Mario Martínez
  • Cristina Montero

Graduate Students

  • Bruna Calsina
  • María Monteagudo
  • Juan María Roldán
  • María Santos


  • Eduardo Gil
  • Javier Lanillos
  • Rocío Letón

Our Group is mainly interested in identifying genetic risk factors involved in endocrine tumour susceptibility. Through a comprehensive analysis of tumour genomic features we have been able to propose diagnostic and prognostic markers, to identify altered pathways that could be therapeutically targeted, and to identify new major susceptibility genes.

We are also interested in defining markers associated with differences in anticancer drug response and toxicity. We are applying targeted and whole-exome next-generation sequencing to a large series of clinically well-characterised patients. The aim is to identify new therapeutic approaches to personalise cancer treatment. These efforts will collectively improve the diagnosis, prognosis and treatment of patients.